US › Healthcare

Teleflex Incorporated (TFX)

US · Healthcare · Medical Instruments & Supplies

$140.12+0.30%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$548.3M
Revenue YoY
-21.8%
Net profit
$-8.2M
Profit YoY
-108.6%
EPS
$1.39
EPS estimate
$1.21
Net margin
-1.5%

EPS came in at 1.39 against a street estimate of 1.21 — a beat of 14.9%.

Key statistics

Market cap
$6.05B
P/E
2,734.2
Forward P/E
20.7
P/B
1.96
Book value
$69.68
EPS (TTM)
$0.05
Dividend yield
1.03%
52-week high
$139.31
52-week low
$99.63
50-day MA
$131.06
200-day MA
$121.13
Beta
0.82

Analyst view

Analysts rate Teleflex Incorporated a hold (2 buy, 11 hold, 1 sell out of 14) with an average price target of $148.55.

Shareholding

Insiders
0.47%
Institutions
108.90%

Largest institutional holders

FundStake
BlackRock Inc12.18%
HHG PLC9.69%
T. Rowe Price Investment Management,Inc.8.67%
Vanguard Portfolio Management, LLC5.51%
Vanguard Capital Management, LLC4.48%
Baupost Group LLC3.60%
Sessa Capital, L.P3.45%
State Street Corp3.39%

Recent filings & reports

DocumentDate
Material agreement · Q2 20262026-06-15
Board / officer change · Q2 20262026-06-09
Company announcement · Q2 20262026-06-02
Reg FD disclosure · Q2 20262026-06-01
Quarterly report · Q1 20262026-05-07
Proxy statement · Q2 20262026-04-13
Annual report FY20252026-02-27
Quarterly report · Q3 20252025-11-06

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Teleflex Incorporated — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.